, Tracking Stock Market Picks
Enter Symbol:
Micrus Endovascular Corporation (MEND) [hlAlert]

up 25.00 %

Micrus Endovascular Corporation (MEND) rated Outperform with price target $14 by Robert W. Baird

Posted on: Friday,  Sep 4, 2009  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Micrus Endovascular Corporation (NASDAQ: MEND) on 09/04/2009, when the stock price was $12.00.
Since then, Micrus Endovascular Corporation has gained 25.00% as of 09/27/2010's recent price of $15.00.
If you would have followed this Robert W. Baird's recommendation on MEND, you would have gained 25% of your investment in 388 days.

Micrus Endovascular Corporation develops, manufactures and markets implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Its products are used by interventional neuroradiologists, interventional neurologists and endovascular trained neurosurgeons to treat cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Its product lines consist of endovascular devices that enable a physician to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Its line of embolic coils anatomically conform and deploy within an aneurysm, forming a scaffold and filling that conforms to a diversity of aneurysm shapes and sizes. In addition, its Cerecyte microcoil product line incorporates bioactive filaments of an absorbable material called polyglycolic acid (PGA), which reside within the central lumen of its microcoils.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/4/2009 8:25 AM Buy
12.00 14.00
as of 12/31/2009
1 Week up  55.48 %
1 Month up  77.71 %
3 Months up  80.46 %
1 YTD up  94.75 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy